Credit Suisse’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-82,800
| Closed | -$18.6M | – | 3608 |
|
|
2021
Q4 | $18.6M | Sell |
82,800
-8,400
| -9% | -$1.77M | 0.01% | 1125 |
|
|
2021
Q3 | $19.4M | Buy |
91,200
+34,100
| +60% | +$7.85M | 0.01% | 1097 |
|
|
2021
Q2 | $13.9M | Sell |
57,100
-22,300
| -28% | -$5.49M | 0.01% | 1357 |
|
|
2021
Q1 | $19.8M | Sell |
79,400
-7,100
| -8% | -$1.69M | 0.01% | 1174 |
|
|
2020
Q4 | $19.9M | Sell |
86,500
-16,300
| -16% | -$3.76M | 0.01% | 1167 |
|
|
2020
Q3 | $26.1M | Buy |
102,800
+36,500
| +55% | +$9.04M | 0.02% | 886 |
|
|
2020
Q2 | $15.6M | Sell |
66,300
-2,900
| -4% | -$662K | 0.01% | 1068 |
|
|
2020
Q1 | $14M | Sell |
69,200
-24,000
| -26% | -$5.24M | 0.01% | 1007 |
|
|
2019
Q4 | $22.5M | Buy |
93,200
+67,500
| +263% | +$14.9M | 0.02% | 959 |
|
|
2019
Q3 | $4.97M | Sell |
25,700
-14,900
| -37% | -$2.86M | ﹤0.01% | 1766 |
|
|
2019
Q2 | $7.48M | Sell |
40,600
-30,200
| -43% | -$5.41M | 0.01% | 1490 |
|
|
2019
Q1 | $13.5M | Sell |
70,800
-80,000
| -53% | -$15.3M | 0.01% | 1068 |
|
|
2018
Q4 | $29.4M | Buy |
150,800
+110,800
| +277% | +$21.6M | 0.03% | 588 |
|
|
2018
Q3 | $8.29M | Sell |
40,000
-200
| -0.5% | -$39.4K | 0.01% | 1368 |
|
|
2018
Q2 | $7.42M | Sell |
40,200
-120,000
| -75% | -$21.2M | 0.01% | 1447 |
|
|
2018
Q1 | $27.3M | Sell |
160,200
-19,800
| -11% | -$3.63M | 0.03% | 695 |
|
|
2017
Q4 | $31.3M | Sell |
180,000
-35,800
| -17% | -$6.34M | 0.03% | 632 |
|
|
2017
Q3 | $40.2M | Sell |
215,800
-38,800
| -15% | -$6.87M | 0.04% | 492 |
|
|
2017
Q2 | $43.9M | Buy |
254,600
+114,700
| +82% | +$18.7M | 0.04% | 449 |
|
|
2017
Q1 | $23M | Buy |
+139,900
| New | +$23.2M | 0.02% | 758 |
|
|
2015
Q3 | – | Sell |
-220,000
| Closed | -$33.8M | – | 4248 |
|
|
2015
Q2 | $33.8M | Sell |
220,000
-150,000
| -41% | -$24M | 0.03% | 576 |
|
|
2015
Q1 | $59.1M | Sell |
370,000
-227,500
| -38% | -$35.8M | 0.06% | 353 |
|
|
2014
Q4 | $95.2M | Buy |
597,500
+330,000
| +123% | +$51.4M | 0.08% | 233 |
|
|
2014
Q3 | $37.6M | Sell |
267,500
-35,000
| -12% | -$4.57M | 0.03% | 628 |
|
|
2014
Q2 | $35.8M | Hold |
302,500
| – | – | 0.03% | 643 |
|
|
2014
Q1 | $37.3M | Sell |
302,500
-302,200
| -50% | -$36.7M | 0.04% | 545 |
|
|
2013
Q4 | $69M | Hold |
604,700
| – | – | 0.06% | 299 |
|
|
2013
Q3 | $67.7M | Sell |
604,700
-25,000
| -4% | -$2.71M | 0.07% | 262 |
|
|
2013
Q2 | $62.1M | Buy |
+629,700
| New | +$65.3M | 0.06% | 306 |
|
Other funds holding AMGN
Credit Suisse's AMGN Position: Q1 2024 in Review
Credit Suisse reduced its Amgen (AMGN) stake by 5.1% in Q1 2024, selling an estimated $17.2M and leaving 1,096,086 shares worth $312M. The position accounts for 0.3% of the portfolio, ranked #58.
Credit Suisse first reported a position in AMGN in Q2 2013 and has held it in 44 quarters since. The position peaked at $690M in Q3 2014. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.
- Credit Suisse held 1,096,086 shares of Amgen worth $312M as of Q1 2024.
- Credit Suisse sold 58,708 Amgen shares in Q1 2024, an estimated $17.2M.
- Amgen made up 0.3% of Credit Suisse's portfolio in Q1 2024, its #58 holding.
- Credit Suisse first reported a position in Amgen in Q2 2013 and has held it in 44 quarters since.
- Credit Suisse's Amgen position peaked at $690M in Q3 2014.
- 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.